Seeking Alpha

Jason Aycock

Jason Aycock
Send Message
View as an RSS Feed
View Jason Aycock's Comments BY TICKER:
Latest  |  Highest rated
  • House Republicans - including House Majority Leader Eric Cantor - are reportedly overwhelmingly opposed to the fiscal cliff deal approved by the Senate. The House appears poised to amend the deal and send it back to the Senate, setting up a legislative high-wire act. [View news story]
    We're "over" the cliff, so they could say that now. Some people are asking why the House GOP is so intransigent after November's election, but this is still the old House.

    A new Congress is sworn in at noon Thursday, and will likely have to start all over again on this in House and Senate.
    Jan 1, 2013. 04:37 PM | 2 Likes Like |Link to Comment
  • Israeli-based SodaStream (SODA -2.5%) could see a disruption to operations with over 30K reservists being called up to duty in the nation. The company disclosed previously in a regulatory filing that the absence of key employees or officers could have an impact on its business. (SEC 20-F filing[View news story]
    I made a change to this item to link out to First Adopter's Twitter ... nothing was "stolen" here (the point's not entirely un-generic, and reservist risk has been discussed before and doesn't just affect SODA), but @firstadopter was out there pointing it out aggressively on Twitter, and we're happy to tip our hat to that ...
    --Jason
    Managing Editor, Market Currents
    Nov 15, 2012. 05:00 PM | Likes Like |Link to Comment
  • U.S. stock markets will close Monday and perhaps Tuesday due to concerns about market integrity related to Hurricane Sandy, Reuters is reporting. [View news story]
    "They" are saying that with order recoding and customer confusion over a partial shutdown it led them to be conservative. And it's starting to look like a Tuesday shutdown is settling in as a certainty with many of them.
    Oct 29, 2012. 02:38 AM | Likes Like |Link to Comment
  • Details on market closings: All U.S. equity markets will close - including NYSE and Nasdaq/BATS, and Nasdaq derivatives exchanges as well as Nasdaq/Finra TRF - and won't trade, electronically or otherwise, on Monday, the SEC confirms. It's a step beyond closing just floor trading, as previously reported. A decision about whether stock markets will open Tuesday will likely come tomorrow. (Updated: Nasdaq details; CBOE; CME confirms opening[View news story]
    Added word to clarify: Nasdaq derivatives exchanges. Details are still trickling out from various markets.
    Oct 28, 2012. 11:46 PM | Likes Like |Link to Comment
  • WEB.COM (WWWW): Q3 EPS of $0.41 beats by $0.02. Revenue of $124.2M beats by $0.7M. Shares +2.1% AH. (PR[View news story]
    This item's been adjusted to note that non-GAAP revenue (adding back a fair-value adjustment to acquired deferred revenue) of $124.2M beat analysts' expectations as well as the company's.
    Oct 26, 2012. 11:44 AM | Likes Like |Link to Comment
  • Hercules Offshore (HERO): Q3 EPS of -$0.10 misses by $0.01. Revenue of $184.9M (+14% Y/Y) beats by $1.5M. (PR[View news story]
    We've adjusted this item to account for non-GAAP measures (impairment of Hercules 252 and 258; gain from sale of Platform Rig 3, insurance settlement on Hercules 185 that were pretax items).
    Oct 25, 2012. 08:45 AM | Likes Like |Link to Comment
  • Insurers are taking an even more cautious stance on Questcor's (QCOR -4.1%) Acthar, according to a Citron Research report. The short seller is now claiming that Humana (HUM -1.5%) has issued a new Commercial Preauthorization document containing a new, specifically asterisked preauthorization for reimbursement for Acthar, which it contends is part of a pattern of insurers taking a more restrictive stance on authorization policy with regard to the drug's reimbursement. [View news story]
    A few things about this.

    For those saying they want to read the relevant docs and make up their own mind -- the claim and the Humana doc are prominently linked above so you can do so. That's the best outcome of an item like this: You're informed about something that might be moving the stock, and are able to see for yourself whether there's anything to it.

    Many of us have noted that Citron is publishing bearish reports this week, and the stock is moving off of that. This item alerted investors to the Friday occurrence of that, nothing more. That's not "associating with" or "endorsing" a point of view on buying or selling; let's be clear about that. Market Currents is an alerts-based feature; the alternative would be just leaving investors to their own devices to find out what's up with QCOR on Friday?

    I think if you're long, you welcome the opportunity to see for yourself what's going on -- if anything -- and then have a platform from which to respond/refute ... whether in a long comment thread, or an instablog or article of your own.

    Heading into earnings I'm looking forward to information from involved investors like some of you to shed some light on the details of preauthorization and enrollment-period changes and make your own case for (or against) the stock.
    Oct 20, 2012. 03:24 PM | Likes Like |Link to Comment
  • Insurers are taking an even more cautious stance on Questcor's (QCOR -4.1%) Acthar, according to a Citron Research report. The short seller is now claiming that Humana (HUM -1.5%) has issued a new Commercial Preauthorization document containing a new, specifically asterisked preauthorization for reimbursement for Acthar, which it contends is part of a pattern of insurers taking a more restrictive stance on authorization policy with regard to the drug's reimbursement. [View news story]
    Folks, regarding any factual dispute here, this item states that Citron is pointing to the new Humana doc, and that Citron is claiming (not proving) that this means a tighter stance on authorization. The Market Current notes Citron is a short seller.

    Is any of that in dispute?
    Oct 19, 2012. 07:24 PM | Likes Like |Link to Comment
  • Bernanke: No new stimulus measures are outlined, but as usual, he says the Fed stands ready to act as needed. The cost of non-traditional policies (QE) "appear manageable." The economy is "far from satisfactory," and labor market stagnation creates enormous suffering. [View news story]
    I don't disagree here ... but it reminds me of what people said before: "Whattaya crazy, he's not gonna act now, he'll make a move at Jackson Hole!"
    Aug 31, 2012. 10:15 AM | Likes Like |Link to Comment
  • THQ (THQI): FQ1 EPS of -$3.41 beats by $0.56. Revenue of $38.5M (+33.5% Y/Y) beats by $9M. (PR)  [View news story]
    Adjusted this item to reflect the non-GAAP net sales they are reporting of $38,525,000 (Bigger beat on revenue). GAAP revenue of $133.7M was reduced by deferred revenue impact of $95.2M.
    Aug 6, 2012. 06:03 PM | Likes Like |Link to Comment
  • More from the Netflix (NFLX) Q2: expects Q3 EPS of -$0.10 to $0.14 vs. $0.11. Guides lower for net domestic subscription additions this quarter in part due to Olympics. Domestic streaming sub additions of 530K to total 23.94M; international stream sub additions of 560K to total 3.62M. Domestic DVD net subscription losses of 850K, bringing those subs to 9.24M. Shares -14.3% AH.  [View news story]
    What they say specifically:

    "For Q3 quarter-to-date, our domestic net additions are very nearly the same as Q3 2010 over the comparable partial period. In that quarter two years ago, we finished with 1.8 million domestic net additions. However, in the middle of that quarter, we launched Netflix on the iPhone to great reception, and we don’t have an equivalent launch this quarter. Moreover, this quarter the Olympics are likely to have a negative impact on Netflix viewing and sign-ups. So, our Q3 guidance is 1 million to 1.8 million domestic net adds. If we finish Q3 in the high end of that range, we would remain on track for 7 million domestic net additions for the year; otherwise it would be challenging to achieve that goal by year end. In either case, we are generating impressive growth this year in our most developed market."
    Jul 24, 2012. 04:30 PM | Likes Like |Link to Comment
  • More on the Moody's banking downgrades: A three-notch cut for CS. Two-notch rating cuts for JPM, C, MS, GS; just one notch for BAC. After hours: MS +3.7%; JPM +1%; BAC +1%; C +0.6%. (full statement)  [View news story]
    MS shareholders, for example, had baked in a three-notch cut today, so they're seen as coming off light.
    Jun 21, 2012. 05:37 PM | 4 Likes Like |Link to Comment
  • After 74 years, another venerable Wall Street name - Smith Barney - is falling by the wayside, as Morgan Stanley plans to rename it Morgan Stanley Wealth Management. MS is in a multi-year process to buy the unit from Citigroup.  [View news story]
    YouTube covers the Smith Barney memory hole: http://bit.ly/Lkl4aZ
    Jun 12, 2012. 02:00 PM | Likes Like |Link to Comment
  • Apr. Personal Income and Outlays: Income +0.2% vs. +0.3% expected, +0.4% prior. Personal spending +0.3% vs. +0.3% expected, +0.3% prior. PCE core price index +0.1% m/m vs. +0.2% expected, +0.2% prior.  [View news story]
    Had the Y/Y mixed up with M/M ... it's right now, at +0.1%.
    Jun 1, 2012. 09:15 AM | Likes Like |Link to Comment
  • And now to the rescue: Chesapeake Energy (CHK) says it's gotten a $3B unsecured loan from Goldman Sachs and Jefferies Group, to be repaid from those 2012 asset sales.  [View news story]
    And more info likely to come on an 8:30 a.m. conference call Monday
    May 11, 2012. 07:34 PM | 1 Like Like |Link to Comment
COMMENTS STATS
111 Comments
75 Likes